{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Vemurafenib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Vemurafenib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Vemurafenib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "vemurafenib",
    "trial_2_text": "Vemurafenib  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Vemurafenib Supplement: 60 participants will take Vemurafenib 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Vemurafenib. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Vemurafenib  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "189": 0.29994210600852966,
      "87": 0.29072305560112,
      "188": 0.24386577308177948,
      "123": 0.2428591400384903,
      "78": 0.23104380071163177,
      "64": 0.20435138046741486,
      "20": 0.1938597708940506,
      "17": 0.17685405910015106,
      "173": 0.16945184767246246,
      "177": 0.16128529608249664,
      "21": 0.15325023233890533,
      "49": 0.1509641408920288,
      "68": 0.1420583575963974,
      "37": 0.14032520353794098,
      "9": 0.13699087500572205,
      "14": 0.12446525692939758,
      "114": 0.11964697390794754,
      "46": 0.11930249631404877,
      "29": 0.118744857609272,
      "228": 0.11717577278614044,
      "261": 0.11523772776126862,
      "67": 0.11294955760240555,
      "101": 0.10817880928516388,
      "38": 0.10767442733049393,
      "200": 0.1054917648434639,
      "2": 0.10436811298131943,
      "77": 0.1028275191783905,
      "104": 0.09822264313697815,
      "179": 0.09693100303411484,
      "341": 0.09227756410837173,
      "350": 0.09113408625125885,
      "193": 0.09092948585748672,
      "79": 0.08833567053079605,
      "239": 0.08784770220518112,
      "72": 0.0843384861946106,
      "131": 0.08322764933109283,
      "191": 0.0780331939458847,
      "126": 0.0775018036365509,
      "27": 0.07485248893499374,
      "85": 0.07417473196983337,
      "396": 0.07364646345376968,
      "194": 0.07271704077720642,
      "100": 0.07227766513824463,
      "136": 0.07182211428880692,
      "186": 0.07114986330270767,
      "36": 0.07112454622983932,
      "5": 0.07084008306264877,
      "151": 0.06864219158887863,
      "243": 0.06746424734592438,
      "139": 0.06698162853717804,
      "180": 0.06644448637962341,
      "30": 0.06603508442640305,
      "28": 0.06552000343799591,
      "234": 0.0649324581027031,
      "211": 0.06439556926488876,
      "249": 0.06354163587093353,
      "122": 0.06311008334159851,
      "76": 0.061537329107522964,
      "61": 0.06152716651558876,
      "116": 0.06106040999293327,
      "147": 0.06098544970154762,
      "33": 0.06098264083266258,
      "269": 0.06087321788072586,
      "355": 0.06038852781057358,
      "130": 0.06007073447108269,
      "257": 0.05923007056117058,
      "86": 0.057757385075092316,
      "212": 0.057191401720047,
      "96": 0.05530012771487236,
      "441": 0.05493851751089096,
      "102": 0.05471954122185707,
      "1": 0.0534573532640934,
      "144": 0.05308403819799423,
      "343": 0.052912455052137375,
      "221": 0.05165582150220871,
      "154": 0.0504898875951767,
      "82": 0.050260551273822784,
      "253": 0.04902241751551628,
      "142": 0.04834878072142601,
      "18": 0.04782753437757492,
      "204": 0.04753422737121582,
      "351": 0.04740876331925392,
      "276": 0.04728439077734947,
      "35": 0.047120559960603714,
      "466": 0.04607439413666725,
      "454": 0.04586466774344444,
      "282": 0.04445775970816612,
      "422": 0.04438181594014168,
      "356": 0.04411371797323227,
      "288": 0.04408130794763565,
      "75": 0.043765973299741745,
      "361": 0.043301455676555634,
      "97": 0.04303497448563576,
      "213": 0.04179055616259575,
      "286": 0.041493114084005356,
      "297": 0.040439292788505554,
      "371": 0.03991769254207611,
      "516": 0.03979004919528961,
      "92": 0.03969505801796913,
      "69": 0.03800475597381592
    },
    "trial_2_ae": {
      "189": 0.29994210600852966,
      "87": 0.29072305560112,
      "188": 0.24386577308177948,
      "123": 0.2428591400384903,
      "78": 0.23104380071163177,
      "64": 0.20435138046741486,
      "20": 0.1938597708940506,
      "17": 0.17685405910015106,
      "173": 0.16945184767246246,
      "177": 0.16128529608249664,
      "21": 0.15325023233890533,
      "49": 0.1509641408920288,
      "68": 0.1420583575963974,
      "37": 0.14032520353794098,
      "9": 0.13699087500572205,
      "14": 0.12446525692939758,
      "114": 0.11964697390794754,
      "46": 0.11930249631404877,
      "29": 0.118744857609272,
      "228": 0.11717577278614044,
      "261": 0.11523772776126862,
      "67": 0.11294955760240555,
      "101": 0.10817880928516388,
      "38": 0.10767442733049393,
      "200": 0.1054917648434639,
      "2": 0.10436811298131943,
      "77": 0.1028275191783905,
      "104": 0.09822264313697815,
      "179": 0.09693100303411484,
      "341": 0.09227756410837173,
      "350": 0.09113408625125885,
      "193": 0.09092948585748672,
      "79": 0.08833567053079605,
      "239": 0.08784770220518112,
      "72": 0.0843384861946106,
      "131": 0.08322764933109283,
      "191": 0.0780331939458847,
      "126": 0.0775018036365509,
      "27": 0.07485248893499374,
      "85": 0.07417473196983337,
      "396": 0.07364646345376968,
      "194": 0.07271704077720642,
      "100": 0.07227766513824463,
      "136": 0.07182211428880692,
      "186": 0.07114986330270767,
      "36": 0.07112454622983932,
      "5": 0.07084008306264877,
      "151": 0.06864219158887863,
      "243": 0.06746424734592438,
      "139": 0.06698162853717804,
      "180": 0.06644448637962341,
      "30": 0.06603508442640305,
      "28": 0.06552000343799591,
      "234": 0.0649324581027031,
      "211": 0.06439556926488876,
      "249": 0.06354163587093353,
      "122": 0.06311008334159851,
      "76": 0.061537329107522964,
      "61": 0.06152716651558876,
      "116": 0.06106040999293327,
      "147": 0.06098544970154762,
      "33": 0.06098264083266258,
      "269": 0.06087321788072586,
      "355": 0.06038852781057358,
      "130": 0.06007073447108269,
      "257": 0.05923007056117058,
      "86": 0.057757385075092316,
      "212": 0.057191401720047,
      "96": 0.05530012771487236,
      "441": 0.05493851751089096,
      "102": 0.05471954122185707,
      "1": 0.0534573532640934,
      "144": 0.05308403819799423,
      "343": 0.052912455052137375,
      "221": 0.05165582150220871,
      "154": 0.0504898875951767,
      "82": 0.050260551273822784,
      "253": 0.04902241751551628,
      "142": 0.04834878072142601,
      "18": 0.04782753437757492,
      "204": 0.04753422737121582,
      "351": 0.04740876331925392,
      "276": 0.04728439077734947,
      "35": 0.047120559960603714,
      "466": 0.04607439413666725,
      "454": 0.04586466774344444,
      "282": 0.04445775970816612,
      "422": 0.04438181594014168,
      "356": 0.04411371797323227,
      "288": 0.04408130794763565,
      "75": 0.043765973299741745,
      "361": 0.043301455676555634,
      "97": 0.04303497448563576,
      "213": 0.04179055616259575,
      "286": 0.041493114084005356,
      "297": 0.040439292788505554,
      "371": 0.03991769254207611,
      "516": 0.03979004919528961,
      "92": 0.03969505801796913,
      "69": 0.03800475597381592
    }
  },
  "safety": {
    "trial_1_safety": 0.4249700605869293,
    "trial_2_safety": 0.4249700605869293
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.47733065485954285
  }
}